These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Volatiles of Pseudomonas aeruginosa and related species by automated headspace concentration--gas chromatography. Zechman JM; Labows JN Can J Microbiol; 1985 Mar; 31(3):232-7. PubMed ID: 3924382 [TBL] [Abstract][Full Text] [Related]
3. Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. Labows JN; McGinley KJ; Webster GF; Leyden JJ J Clin Microbiol; 1980 Oct; 12(4):521-6. PubMed ID: 6775012 [TBL] [Abstract][Full Text] [Related]
4. Analysis of amines and other bacterial products by head-space gas chromatography. Larsson L; Mårdh PA; Odham G Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):207-13. PubMed ID: 358746 [TBL] [Abstract][Full Text] [Related]
5. Discrimination of bacteria by rapid sensing their metabolic volatiles using an aspiration-type ion mobility spectrometer (a-IMS) and gas chromatography-mass spectrometry GC-MS. Ratiu IA; Bocos-Bintintan V; Patrut A; Moll VH; Turner M; Thomas CLP Anal Chim Acta; 2017 Aug; 982():209-217. PubMed ID: 28734362 [TBL] [Abstract][Full Text] [Related]
6. Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry. Boots AW; Smolinska A; van Berkel JJ; Fijten RR; Stobberingh EE; Boumans ML; Moonen EJ; Wouters EF; Dallinga JW; Van Schooten FJ J Breath Res; 2014 Jun; 8(2):027106. PubMed ID: 24737039 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry. Chen J; Tang J; Shi H; Tang C; Zhang R J Basic Microbiol; 2017 Mar; 57(3):228-237. PubMed ID: 27874211 [TBL] [Abstract][Full Text] [Related]
8. Volatile organic compounds in headspace characterize isolated bacterial strains independent of growth medium or antibiotic sensitivity. Hintzen KFH; Blanchet L; Smolinska A; Boumans ML; Stobberingh EE; Dallinga JW; Lubbers T; van Schooten FJ; Boots AW PLoS One; 2024; 19(1):e0297086. PubMed ID: 38277384 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa. Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902 [TBL] [Abstract][Full Text] [Related]
11. A new and rapid method for the assay of bacterial fatty acids using high resolution capillary gas chromatography and trimethylsulfonium hydroxide. Müller KD; Husmann H; Nalik HP Zentralbl Bakteriol; 1990 Nov; 274(2):174-82. PubMed ID: 2128179 [TBL] [Abstract][Full Text] [Related]
12. GC-IMS headspace analyses allow early recognition of bacterial growth and rapid pathogen differentiation in standard blood cultures. Drees C; Vautz W; Liedtke S; Rosin C; Althoff K; Lippmann M; Zimmermann S; Legler TJ; Yildiz D; Perl T; Kunze-Szikszay N Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):9091-9101. PubMed ID: 31664484 [TBL] [Abstract][Full Text] [Related]
13. The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus. Ricci A; Coppo E; Barbieri R; Debbia EA; Marchese A J Chemother; 2017 Apr; 29(2):67-73. PubMed ID: 27285830 [TBL] [Abstract][Full Text] [Related]
14. Head-space gas-liquid chromatographic analysis for presumptive identification of bacteria in blood cultures. Ho SW Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):18-26. PubMed ID: 3816354 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [TBL] [Abstract][Full Text] [Related]
16. The volatile metabolome of Klebsiella pneumoniae in human blood. Rees CA; Smolinska A; Hill JE J Breath Res; 2016 May; 10(2):027101. PubMed ID: 27163334 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the disagreement between automated bioluminescence-based and culture methods for detecting significant bacteriuria, with proposals for standardizing evaluations of bacteriuria detection methods. Nichols WW; Curtis GD; Johnston HH J Clin Microbiol; 1982 May; 15(5):802-9. PubMed ID: 6808012 [TBL] [Abstract][Full Text] [Related]
18. Expanding the Klebsiella pneumoniae volatile metabolome using advanced analytical instrumentation for the detection of novel metabolites. Rees CA; Franchina FA; Nordick KV; Kim PJ; Hill JE J Appl Microbiol; 2017 Mar; 122(3):785-795. PubMed ID: 27930839 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436 [TBL] [Abstract][Full Text] [Related]
20. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]